Brown Brothers Harriman & Co’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-287,902
| Closed | -$636K | – | 1324 |
|
|
2023
Q2 | $636K | Hold |
287,902
| – | – | 0.01% | 299 |
|
|
2023
Q1 | $731K | Hold |
287,902
| – | – | 0.01% | 286 |
|
|
2022
Q4 | $538K | Hold |
287,902
| – | – | ﹤0.01% | 307 |
|
|
2022
Q3 | $740K | Hold |
287,902
| – | – | 0.01% | 253 |
|
|
2022
Q2 | $556K | Hold |
287,902
| – | – | ﹤0.01% | 294 |
|
|
2022
Q1 | $855K | Hold |
287,902
| – | – | 0.01% | 271 |
|
|
2021
Q4 | $1.29K | Hold |
287,902
| – | – | 0.01% | 217 |
|
|
2021
Q3 | $1.4K | Hold |
287,902
| – | – | 0.01% | 190 |
|
|
2021
Q2 | $1.96K | Hold |
287,902
| – | – | 0.01% | 169 |
|
|
2021
Q1 | $2.03K | Hold |
287,902
| – | – | 0.01% | 164 |
|
|
2020
Q4 | $1.8M | Hold |
287,902
| – | – | 0.01% | 170 |
|
|
2020
Q3 | $1.56M | Hold |
287,902
| – | – | 0.01% | 169 |
|
|
2020
Q2 | $1.5M | Hold |
287,902
| – | – | 0.01% | 170 |
|
|
2020
Q1 | $907K | Hold |
287,902
| – | – | 0.01% | 204 |
|
|
2019
Q4 | $1.16M | Hold |
287,902
| – | – | 0.01% | 227 |
|
|
2019
Q3 | $1.24M | Hold |
287,902
| – | – | 0.01% | 209 |
|
|
2019
Q2 | $1.15M | Hold |
287,902
| – | – | 0.01% | 208 |
|
|
2019
Q1 | $1.54M | Hold |
287,902
| – | – | 0.01% | 172 |
|
|
2018
Q4 | $1.48M | Hold |
287,902
| – | – | 0.01% | 166 |
|
|
2018
Q3 | $2.79M | Hold |
287,902
| – | – | 0.02% | 129 |
|
|
2018
Q2 | $2.94M | Hold |
287,902
| – | – | 0.02% | 123 |
|
|
2018
Q1 | $3.74M | Hold |
287,902
| – | – | 0.02% | 110 |
|
|
2017
Q4 | $5.15M | Hold |
287,902
| – | – | 0.03% | 97 |
|
|
2017
Q3 | $7.23M | Sell |
287,902
-80,000
| -22% | -$1.86M | 0.04% | 79 |
|
|
2017
Q2 | $8.87M | Hold |
367,902
| – | – | 0.05% | 73 |
|
|
2017
Q1 | $7.08M | Hold |
367,902
| – | – | 0.04% | 82 |
|
|
2016
Q4 | $5.67M | Hold |
367,902
| – | – | 0.03% | 89 |
|
|
2016
Q3 | $4.79M | Hold |
367,902
| – | – | 0.03% | 90 |
|
|
2016
Q2 | $5.12M | Hold |
367,902
| – | – | 0.03% | 92 |
|
|
2016
Q1 | $5.58M | Hold |
367,902
| – | – | 0.03% | 96 |
|
|
2015
Q4 | $6.98M | Hold |
367,902
| – | – | 0.04% | 88 |
|
|
2015
Q3 | $6.99M | Hold |
367,902
| – | – | 0.04% | 90 |
|
|
2015
Q2 | $9.48M | Buy |
+367,902
| New | +$10.4M | 0.04% | 76 |
|
Brown Brothers Harriman & Co's PRTK Position: Q3 2023 in Review
Brown Brothers Harriman & Co sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 287,902 shares — an estimated $636K sold.
Brown Brothers Harriman & Co first reported a position in PRTK in Q2 2015 and held it in 33 quarters. The position peaked at $9.48M in Q2 2015. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- Brown Brothers Harriman & Co reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Brown Brothers Harriman & Co sold 287,902 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $636K.
- Brown Brothers Harriman & Co first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2015 and held it in 33 quarters.
- Brown Brothers Harriman & Co's Paratek Pharmaceuticals, Inc. position peaked at $9.48M in Q2 2015.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on Brown Brothers Harriman & Co's 13F filing for Q3 2023, filed 13 Nov 2023.